72 related articles for article (PubMed ID: 16010251)
1. Invasive cardiac aspergillosis in an immuno-competent patient: distinctive imaging features on 18F-fluorodeoxyglucose (FDG)-PET/CT and 99mTc-sestamibi SPECT myocardial perfusion imaging.
Subramanian K; Bahl A; Singh H; Singh H; Mittal BR
J Nucl Cardiol; 2023 Dec; 30(6):2825-2827. PubMed ID: 37055699
[No Abstract] [Full Text] [Related]
2. Myocardial perfusion imaging with 99mTc-labeled radiopharmaceuticals: How fast can a stress-rest same-day imaging protocol be completed?
Taillefer R
J Nucl Cardiol; 2017 Aug; 24(4):1328-1331. PubMed ID: 27044387
[No Abstract] [Full Text] [Related]
3. Comparison of effective dose and lifetime risk of cancer incidence of CT attenuation correction acquisitions and radiopharmaceutical administration for myocardial perfusion imaging.
Tootell AK; Szczepura K; Hogg P
Br J Radiol; 2014 Sep; 87(1041):20140110. PubMed ID: 24998249
[TBL] [Abstract][Full Text] [Related]
4. Is faster always better? What is the implication of a shorter time to imaging with tetrofosmin compared to sestamibi?
Laipply K; Gerson M
J Nucl Cardiol; 2021 Dec; 28(6):2629-2632. PubMed ID: 32405990
[No Abstract] [Full Text] [Related]
5. What is this image? 2019: Image 5 result : Gastroesophageal reflux: An unexpected cause of chest pain identified by review of planar images and coregistered SPECT-CT images.
Gupta JI; Corbett JR; Murthy VL; Weinberg RL
J Nucl Cardiol; 2019 Apr; 26(2):367-369. PubMed ID: 30719654
[No Abstract] [Full Text] [Related]
6. Use of 99m-technetium-glucoheptonate as a tracer for brain tumor imaging: An overview of its strengths and pitfalls.
Santra A; Kumar R; Sharma P
Indian J Nucl Med; 2015; 30(1):1-8. PubMed ID: 25589798
[TBL] [Abstract][Full Text] [Related]
7. Imaging probes for non-invasive tumoral detection and functional monitoring of cancer multidrug resistance.
Mendes F; Gano L; Grilo J; Cunha S; Fernandes C; Paulo A
Cancer Drug Resist; 2020; 3(2):209-224. PubMed ID: 35582609
[No Abstract] [Full Text] [Related]
8. Different Efflux Transporter Affinity and Metabolism of
Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K
Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970
[TBL] [Abstract][Full Text] [Related]
9. The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.
Nuvoli S; Galassi S; Gelo I; Rocchitta G; Fancellu A; Serra PA; Madeddu G; Spanu A
Oncol Rep; 2018 May; 39(5):2055-2062. PubMed ID: 29512735
[TBL] [Abstract][Full Text] [Related]
10. Comparison of (99m)tc-tetrofosmin and (99m)tc-sestamibi uptake in glioma cell lines: the role of p-glycoprotein expression.
Alexiou GA; Xourgia X; Vartholomatos E; Tsiouris S; Kalef-Ezra JA; Fotopoulos AD; Kyritsis AP
Int J Mol Imaging; 2014; 2014():471032. PubMed ID: 25436147
[TBL] [Abstract][Full Text] [Related]
11. A hardware investigation of robotic SPECT for functional and molecular imaging onboard radiation therapy systems.
Yan S; Bowsher J; Tough M; Cheng L; Yin FF
Med Phys; 2014 Nov; 41(11):112504. PubMed ID: 25370663
[TBL] [Abstract][Full Text] [Related]
12. SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.
Palumbo B; Buresta T; Nuvoli S; Spanu A; Schillaci O; Fravolini ML; Palumbo I
Int J Mol Sci; 2014 Jun; 15(6):9878-93. PubMed ID: 24897023
[TBL] [Abstract][Full Text] [Related]
13. Is there a Role for Spect with (99m)Tc-Tetrofosmin in the Diagnostic Work Up of a Brain Tumor?
Birbilis T; Boussios N; Papatheodossiou L; Matis G; Zissimopoulos A
Maedica (Bucur); 2013 Sep; 8(4):347-50. PubMed ID: 24790666
[TBL] [Abstract][Full Text] [Related]
14. Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.
Kong FL; Ford RJ; Yang DJ
Biomed Res Int; 2013; 2013():626910. PubMed ID: 23841079
[TBL] [Abstract][Full Text] [Related]
15. Translational molecular imaging for cancer.
Pomper MG
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S16-26. PubMed ID: 16361132
[TBL] [Abstract][Full Text] [Related]
16. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.
Schillaci O; Spanu A; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):133-44. PubMed ID: 16010251
[TBL] [Abstract][Full Text] [Related]
17. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
Schillaci O
Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
[TBL] [Abstract][Full Text] [Related]
18. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
19. 99mTc labelled cationic lipophilic complexes in malignant and benign tumors: the role of SPET and pinhole-SPET in breast cancer, differentiated thyroid carcinoma and hyperparathyroidism.
Spanu A; Schillaci O; Madeddu G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):145-69. PubMed ID: 16010252
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
